Rhovica Neuroimaging, a Bern-based MedTech startup, has raised €2.5 million in a financing spherical to speed up the event of SoNav, Rhovica’s bedside navigation system for extraventricular drainage (EVD) catheters utilized in emergency neurosurgery.
The spherical was led by M2care, with participation from Kickfund, Valuemaker and several other different enterprise angels.
Martin Hlavica, CEO and Co-founder of Rhovica, said: “This fundraising marks an essential milestone for Rhovica. The belief of our buyers strengthens our means to advance the event of SoNav and transfer nearer to creating this answer accessible to sufferers in want.”
Rhovica Neuroimaging, based in 2023 by neurosurgeons Martin Hlavica and Thomas Rhomberg, is innovating options to enhance emergency therapy for sufferers with life- threatening elevated mind stress.
In response to the corporate, one of the crucial frequent procedures in such instances is the position of an EVD to alleviate harmful elevated mind stress. At present, that is usually carried out freehand on the bedside – quick however imprecise – or with navigation methods within the working room, which delays pressing care. This trade-off between pace and accuracy can apperently worsen affected person outcomes.
Rhovica’s SoNav system goals to handle this problem with built-in sensors that present real-time visualisation for guided catheter insertion immediately on the bedside. The expertise will even reportedly allow steady monitoring of mind ventricles, lowering repeated CT scans, bettering security and outcomes, and decreasing prices.
Florence Thueux, President of M2care, commented: “M2care combines funding capability with hands-on experience to de-risk early HealthTech ventures to Collection A readiness. Rhovica displays this strategy: addressing a transparent medical want with a powerful workforce and a expertise that may remodel emergency neurosurgery. We’re proud to actively assist the corporate on this subsequent section of improvement.”
Rhovica addresses a essential problem in emergency neurosurgery: the protected and quick placement of life-saving EVD catheters to alleviate elevated intracranial stress, for instance after extreme trauma or intracranial bleeding.
With this strategy, the corporate positions itself within the rising neurosurgical system market atmosphere, which is anticipated to develop between 4.5% and 14.2% within the coming years – as per figures supplied by Rhovica.
To additional strengthen its improvement, Rhovica has appointed Carsten Laue, Managing Director at M2care, to its Board of Administrators. His experience in medtech technique and firm constructing will assist the corporate in advancing SoNavTM towards medical adoption.
Laue added: “By becoming a member of Rhovica’s board, I stay up for actively supporting the workforce in translating a powerful medical want right into a viable MedTech answer. The mission’s origin in emergency neurosurgical care, mixed with the founders’ complementary experience, displays exactly the kind of innovation that M2care is ready as much as speed up.”
